The key reasons why CRISPR Therapeutics AG (CRSP) is -47.55% away from 52-week high?
CRISPR Therapeutics AG (NASDAQ: CRSP) open the trading on Wednesday, with a bit cautious approach as it glided -4.35% to $35.60, before settling in for
CRISPR Therapeutics AG (NASDAQ: CRSP) open the trading on Wednesday, with a bit cautious approach as it glided -4.35% to $35.60, before settling in for
On Friday, CRISPR Therapeutics AG (NASDAQ: CRSP) opened lower -1.44% from the last session, before settling in for the closing price of $36.14. Price fluctuations
CRISPR Therapeutics AG (NASDAQ: CRSP) established initial surge of 3.29% at $34.25, as the Stock market unbolted on Wednesday, before settling in for the price
CRISPR Therapeutics AG (NASDAQ: CRSP) on Friday, soared 1.38% from the previous trading day, before settling in for the closing price of $37.73. Within the
CRISPR Therapeutics AG (NASDAQ: CRSP) started the day on Wednesday, with a price increase of 3.40% at $38.67, before settling in for the price of
On Friday, CRISPR Therapeutics AG (NASDAQ: CRSP) opened lower -2.15% from the last session, before settling in for the closing price of $39.11. Price fluctuations
Witnessing the stock’s movement on the chart, on Wednesday, CRISPR Therapeutics AG (NASDAQ: CRSP) had a quiet start as it plunged -1.76% to $38.54, before
A new trading day began on Thursday, with CRISPR Therapeutics AG (NASDAQ: CRSP) stock price down -0.03% from the previous day of trading, before settling
CRISPR Therapeutics AG (NASDAQ: CRSP) started the day on Wednesday, with a price decrease of -3.00% at $37.78, before settling in for the price of
On Friday, CRISPR Therapeutics AG (NASDAQ: CRSP) opened higher 14.71% from the last session, before settling in for the closing price of $34.26. Price fluctuations
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.